The effectiveness of a new European chondroprotector in the combination therapy of stage I–II osteoarthritis (OA) of various localizations was assessed. The study included 98 patients with OA of the knee and hip joints, as well as polyosteoarthrosis . According to
This work is licensed under a Creative Commons Attribution 4.0 International License.